New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
October 19, 2009
08:30 EDTCBST
theflyonthewall.com: Cubist Pharmaceuticals and Hydra Biosciences form collaboration
Hydra Biosciences announced that they have entered into an agreement with Cubist Pharmaceuticals for a joint collaboration to develop novel ion channel drugs. The deal focuses on Hydra’s research and development program for ion channel compounds that target the TRPA1 receptor, which is believed to have an important role in pain management. :theflyonthewall.com



News For CBST From The Last 14 Days
Check below for free stories on CBST the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2012
07:02 EDTCBST
theflyonthewall.com: Cubist receives CUBICIN Paragraph IV notice letter
Cubist Pharmaceuticals announced that it has received a Paragraph IV Notice Letter from Hospira advising of the filing of an Abbreviated New Drug Application for a generic version of CUBICIN. :theflyonthewall.com